Skip to content.
About GPO   |   Newsroom/Media   |   Congressional Relations   |   Inspector General   |   Careers   |   Contact   |   askGPO   |   Help  
 

  FDsys > More Information
(Search string is required)
 

13-290 - King et al v. Pfizer, Inc. et al


Download Files

Metadata

Document in Context
13-290 - King et al v. Pfizer, Inc. et al
November 26, 2013
PDF | More
FINDINGS AND RECOMMENDATION - It is Recommended to Chief Judge Laurie Smith Camp that: MOTION to Remand (Filing No. 22) be denied and Monte M. Scott, M.D., be dismissed. Ordered by Magistrate Judge Thomas D. Thalken. (AOA)
December 31, 2013
PDF | More
MEMORANDUM AND ORDER - Magistrate Judge F.A. Gossett's Findings and Recommendation (Filing No.30) are adopted. The Motion to Remand filed by Plaintiffs Cathy King and Steve King (Filing No.[ 22]) is denied. Defendant Monte Scott, M.D., is dismissed as a defendant in theseproceedings. The Clerk's office will modify the caption to reflect the dismissal of Monte Scott, M.D., as a Defendant. Ordered by Chief Judge Laurie Smith Camp. (AOA) Modified on 12/31/2013 (AOA) to add Memorandum.
January 2, 2014
PDF | More
AMENDED MEMORANDUM AND ORDER - Magistrate Judge Thomas D. Thalken's Findings and Recommendation (Filing No. 30) are adopted. The Motion to Remand filed by Plaintiffs Cathy King and Steve King (Filing No. 22) is denied. Defendant Monte Scott, M.D., is dismissed as a defendant in these proceedings. The Clerk's office will modify the caption to reflect the dismissal of Monte Scott, M.D., as a Defendant. Ordered by Chief Judge Laurie Smith Camp. (AOA) Ordered by Chief Judge Laurie Smith Camp. (AOA)
December 17, 2014
PDF | More
ORDER OF DISMISSAL OF A PARTY - The Kings' and Acura's Stipulation to Dismiss Defendant Acura Pharmaceuticals, Inc. without Prejudice (Filing No. 57) is approved. Claims asserted by the Kings against Acura in the above-captioned action are dismissed without prejudice. The parties will pay their own costs and attorney fees. If Acura is affirmatively identified in this action as a manufacturer, seller, distributor, or marketer of metoclopramide provided to Plaintiff Cathy King, it will not assert a statute of limitations defense arising solely as a result of the passage of time between Acura's first receipt of the Kings' complaint and the filing of an amended complaint formally adding Acura as a party. Ordered by Chief Judge Laurie Smith Camp. (GJG)
January 7, 2015
PDF | More
ORDER that the 11/3/2014 order 56 regarding various disclosure deadlines is reaffirmed. Any motion for summary judgment shall be filed on or before 7/15/15. The court will conduct a telephone conference with counsel on 8/17/2015 at 10:00 AM for the purpose of scheduling this matter for trial. Counsel for the plaintiffs shall initiate such telephone conference. Ordered by Magistrate Judge Thomas D. Thalken. (JSF)
March 30, 2016
PDF | More
ORDER denying 96 Plaintiff's Unopposed Motion to Extend Certain Case Progression Deadlines. Any objection to this Order shall be filed with the Clerk within 14 days after being served with a copy of this Order. Ordered by Magistrate Judge Thomas D. Thalken. (JSF)
April 18, 2016
PDF | More
MEMORANDUM AND ORDER overruling the Parties' Joint Objection to Magistrate Judge's Order Denying Unopposed Motion to Extend Certain Case Progression Deadlines 100. Ordered by Chief Judge Laurie Smith Camp. (JSF)
August 19, 2016
PDF | More
MEMORANDUM AND ORDER that the Motion for Summary Judgment (Filing No. 112) submitted by Defendants Pfizer Inc., Wyeth LLC, Wyeth Pharmaceuticals Inc., and Schwarz Pharma, Inc., is granted in part as follows: The Plaintiffs' claims are barred by Nebraska's applicable statute of repose, Neb. Rev. Stat. ยง 25-244(2) (Reissue 1995), And the Motion is otherwise denied; The Plaintiffs' Complaint is dismissed, with prejudice, as to all Defendants. All other pending Motions in this action are denied as moot. The parties will bear their own costs and attorney fees. A separate Judgment will be issued. Ordered by Chief Judge Laurie Smith Camp. (LAC)